USPTO serial 99410386
IMMUNEGPT
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- CHANG, ELIZABETH YI HSUAN
- Law office
- TMO LAW OFFICE 115
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with IMMUNEGPT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Carrie A. Johnson
Carrie A. Johnson Eastman & Smith LtdP.O. Box 10032One Seagate, 27th FloorToledo, OH 43699Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable and recorded software for the processing and analysis of biological and immune data, using machine learning algorithms trained on biological and immune data, immune cell coutns, T cell receptors (TCRs), B cell receptors (BCRs), Immunosenescence, telomere length, and standard blood biomarkers; Downloadable computer software leveraging artificial intelligence, specifically a transformer-based architecture, for the prediction and generation of immune cell receptor sequences; downloadable computer programs for processing paired and unpaired immune cell receptor data for research and educational purposes; downloadable computer software applications for decoding and synthesizing sequence patterns using proprietary tokenization and context-specific learning algorithms. | ACTIVE | — |
| 042 | Scientific and technical research relating to amino acid sequencing and sequences; Providing online, non-downloadable software for conducting advanced bioinformatics research; Software as a service (SaaS) services featuring cloud-based platforms for modelling, analyzing, and generating immune system receptor sequences using AI-driven methodologies; software as a service (SaaS) and machine learning as a service (MLaaS) featuring software using artificial intelligence for conducting biological sequence analysis tailored to immune cells, T cell receptors (TCRs) and B cell receptors (BCRs); Platform as a service (PAAS) featuring computer software platforms for use in data hosting of immune cell sequencing datasets for educational and professional research; developing specialized software frameworks for others that employ causal masking and custom loss functions for immune receptor study; scientific consultation services relating to the use of AI in immunology and molecular biology research; providing online non-downloadable AI-powered software for the evaluation and interpretation of T cell receptor (TCR) and B cell receptor (BCR) sequences to support medical diagnostics and immunological studies; medical research services for the purpose of enabling advanced predictive modelling for immune system behavior; computer software consulting services relating to clinical software applications involving bioinformatics and immune cell sequencing data; development of computer software for others for the purpose of supporting healthcare and therapeutic research by offering tools for understanding immune interactions through data-driven analysis software | ACTIVE | — |
| 044 | Providing medical and clinical analysis services through software for diagnostic and treatment purposes relating to the field of immune cell receptor research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 24, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 24, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 24, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 22, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 15, 2026 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 15, 2026 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Feb 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 19, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 18, 2026 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Feb 18, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 24, 2025 | NWAP | NEW APPLICATION ENTERED | — |